Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Nature Reviews. Cancer|May 12, 2019
Going to extremes: determinants of extraordinary response and survival in patients with cancerFlurina A M Saner, Alan Herschtal, Brad H Nelson, et al.
Cell Reports. Medicine|May 23, 2023
Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomesPaula Cunnea, Edward W Curry, Elizabeth L Christie, et al.
Cancers|November 27, 2021
Phenotypic Consequences of <i>SLC25A40-ABCB1</i> Fusions beyond Drug Resistance in High-Grade Serous Ovarian CancerKathleen I Pishas, Karla J Cowley, Ahwan Pandey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 11, 2019
Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor HistotypeMasataka Takenaka, Martin Köbel, Dale W Garsed, et al.
Cell Reports|November 14, 2019
Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down SyndromeKatherine A Waugh, Paula Araya, Ahwan Pandey, et al.
NPJ Precision Oncology|June 11, 2025
Overcoming intra-tumoral heterogeneity for biomarker discovery in the high-grade serous ovarian cancer proteomeSrikanth S Manda, Maiken M Espersen, Cristina Mapagu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Oxford Classic-defined EMT risk stratification of High Grade Serous Ovarian cancer for guiding treatment decisionsLena Rai, Antonella Ravaggi, Eliana Bignotti, et al.
Nature Genetics|February 28, 2023
Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancerNikki L Burdett, Madelynne O Willis, Kathryn Alsop, et al.
NPJ Precision Oncology|March 14, 2024
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilitiesNicholas W Bateman, Tamara Abulez, Anthony R Soltis, et al.
Nature Genetics|December 1, 2022
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancerDale W Garsed, Ahwan Pandey, Sian Fereday, et al.
Pageof 4